Alpha 2 adrenoceptor- and imidazoline-preferring binding sites in the dog kidney.
Evans
R G
RG
Emily E. E. Stewart Renal Laboratory, Baker Medical Research Institute, Prahran, Victoria, Australia.
Haynes
J M
JM
D058647:Adrenergic alpha-2 Receptor Agonists; D058669:Adrenergic alpha-2 Receptor Antagonists; D000818:Animals; D003000:Clonidine / Q000031:analogs & derivatives / Q000378:metabolism; D004146:Dioxanes / Q000378:metabolism; D004285:Dogs; D019329:Idazoxan; D007093:Imidazoles / Q000378:metabolism; D054755:Imidazoline Receptors; D007668:Kidney / Q000378:metabolism*; D008297:Male; D018341:Receptors, Adrenergic, alpha-2 / Q000378:metabolism*; D011955:Receptors, Drug / Q000378:metabolism*; D015016:Yohimbine / Q000378:metabolism
D058647:Adrenergic alpha-2 Receptor Agonists; D058669:Adrenergic alpha-2 Receptor Antagonists; D004146:Dioxanes; D007093:Imidazoles; D054755:Imidazoline Receptors; D018341:Receptors, Adrenergic, alpha-2; D011955:Receptors, Drug; D015016:Yohimbine; C016986:apraclonidine; D003000:Clonidine; D019329:Idazoxan